Clinical Trial Update: Intralesional HPV Vaccine for Condylomata [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results for an intralesional HPV vaccine targeting genital warts (condylomata acuminata) conducted by UCSF, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Warts
• Human Papillomavirus Infection

Drugs mentioned

• Intralesional HPV Vaccine (HPV vaccine, intralesional)

Snippet

Sponsor: University of California, San Francisco | Conditions: Human Papilloma Virus, Warts | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-02